Finnrick, an independent testing programme, publishes 30 assays for Injectify: 16 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 14 did not. Most recent assay 8 May 2026.
Injectify operates from Canada, Otawa, listed by Finnrick as "Trading". Source: Finnrick, https://www.finnrick.com/vendors/injectify.
Finnrick-tested with mixed results. Tested across 6 peptide products with 29 total samples.
Injectify is listed as inactive — its storefront did not respond when the liveness check last ran. Finnrick Grade C. Finnrick avg score: 7.3/10 across 29 samples (6 products). Mixed quality — some products test well, others below average. domain is still registered but publishes no address record, so it serves no website (checked 2026-08-10).
Injectify holds independent lab grade C, assigned across 29 graded samples, average score 7.3/10. That grade comes from an independent grader's own sampling, not from PeptideAtlas, and it describes the samples that grader obtained rather than every batch sold.
No independent third-party assay is on file for Injectify, and its storefront did not respond when we last tried to read it. An untested vendor has not failed a test — this is an absence of evidence, not evidence against it.
| Product | Assays | Result |
|---|---|---|
| BPC-157 | 7 | 2 passed, 5 failed |
| CJC-1295 | 7 | 0 passed, 7 failed |
| Ipamorelin | 4 | 3 passed, 1 failed |
| Melanotan II | 4 | 4 passed, 0 failed |
| Retatrutide | 4 | 3 passed, 1 failed |
| Semaglutide | 4 | 4 passed, 0 failed |
Source: Finnrick, as published 2026-08-09. Pass and fail are Finnrick's classification against its own threshold, not ours.
| Status | Inactive — storefront unreachable |
|---|---|
| Independent lab grade | C (29 samples) |
| Average grader score | 7.3/10 |
| Vendor type | Research-use supplier |
Injectify is listed as inactive and we hold 30 Finnrick assays (16 passing, 14 failing its purity threshold); an independent lab grade of C. That is evidence about the batches that were tested or published, not a guarantee about the vial you receive.
Yes. Finnrick, an independent testing programme, publishes 30 assays for Injectify: 16 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 14 did not. Most recent assay 8 May 2026.
Similar vendors: Peptide Sciences, Limitless Life Nootropics, Polaris Peptides, NextechLabs, Yiwu Aozuo Trading Co, Shandong Shengyuan Peptide Technology, Bulk Peptide Supply, Skye Peptides.
Popular peptides: Semaglutide, Tirzepatide, Retatrutide, BPC-157, CJC-1295, Ipamorelin.
Other reviewed vendors: Inno Peptides Review, Instant Peptides Review, Ion Peptide Review.